<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00086 Mid Day Module (Pathology-6) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 15517,
    "choices": [
      {
        "id": 62028,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ependymoma</span></span></span></p>"
      },
      {
        "id": 62029,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medulloblastoma</span></span></span></p>"
      },
      {
        "id": 62030,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligodendroglioma</span></span></span></p>"
      },
      {
        "id": 62031,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glioblastoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In reviewing brain imaging studies of various neoplasms, a physician notes the frequent occurrence of intratumoral calcifications. Such calcifications, though not exclusive, are most characteristically associated with which of the following types of primary brain tumors? </span></span></p>",
    "unique_key": "Q1986831",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088025,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Oligodendroglioma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligodendrogliomas </strong>are <strong>tumors </strong>derived from <strong>oligodendrocytes</strong>, a <strong>type of glial cell</strong>. They are known to <strong>undergo calcification</strong>, and this calcification can be visualized on imaging studies. <strong>Oligodendrogliomas </strong>are relatively <strong>slow-growing tumors </strong>and are more commonly <strong>observed in adults</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The other <strong>three tumors </strong>in the options namely <strong>ependymoma</strong>, <strong>medulloblastoma </strong>and <strong>glioblastoma </strong>do <strong>not </strong>undergo <strong>calcification </strong>that frequently. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligodendrogliomas</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>glial cell tumors </strong>with a <strong>propensity for calcification</strong>, often seen on imaging studies, and this feature can aid in their diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Ependymomas,</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> tumors arising from <strong>ependymal cells lining </strong>the <strong>ventricular system</strong>, can have various imaging features, but they are not specifically known for frequent calcification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Medulloblastomas</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which are <strong>malignant childhood tumors </strong>of the <strong>cerebellum</strong>, may show calcification, but it is not as common or pronounced as in oligodendrogliomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glioblastomas</strong> are <strong>highly aggressive brain tumors </strong>that may occasionally show <strong>areas of calcification</strong>; however, calcifications are more characteristic and frequent in oligodendrogliomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligodendroglioma </strong>is the <strong>tumor most commonly associated </strong>with <strong>calcification in adult patients</strong>, a feature that can be <strong>visualized on imaging studies</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1295</span></strong></span></span></p>",
    "correct_choice_id": 62030,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15515,
    "choices": [
      {
        "id": 62020,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meningioma </span></span></span></p>"
      },
      {
        "id": 62021,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemangioma </span></span></span></p>"
      },
      {
        "id": 62022,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glioma </span></span></span></p>"
      },
      {
        "id": 62023,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schwannoma</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Verocay bodies are seen in:</span></span></p>",
    "unique_key": "Q5789338",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088026,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Schwannoma </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schwannomas </strong>are <strong>well-circumscribed</strong>, <strong>encapsulated masses </strong>that abut the <strong>associated nerve without invading it</strong>. <strong>Microscopically</strong>, they are <strong>comprised of an admixture of dense </strong>and <strong>loose areas </strong>referred to as <strong>Antoni A </strong>and <strong>Antoni B </strong>areas, respectively.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>dense eosinophilic Antoni A areas </strong>often contain <strong>spindle cells </strong>arranged into <strong>cellular intersecting fascicles</strong>. <strong>Palisading of nuclei </strong>is common and <strong>&ldquo;nuclear-free zones</strong>&rdquo; that <strong>lie between the regions </strong>of <strong>nuclear palisading </strong>are termed <strong>Verocay bodies</strong>. In the loose, hypocellular Antoni B areas the spindle cells are spread apart by a prominent myxoid extracellular matrix that may be associated with microcyst formation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Meningiomas</strong> may exhibit <strong>whorled patterns </strong>and <strong>psammoma bodies</strong>, Verocay bodies are not a feature of meningiomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Hemangiomas</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>benign tumors </strong>derived from <strong>blood vessels </strong>and can occur in <strong>various tissues </strong>including the <strong>skin and internal organs</strong>. They do not display Verocay bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Gliomas</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>tumors </strong>arising from <strong>glial cells </strong>in the <strong>central nervous system</strong>, including <strong>astrocytes</strong>, <strong>oligodendrocytes</strong>, and <strong>ependymal cells</strong>. They do not have Verocay bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Verocay bodies </strong>are seen in <strong>schwannomas </strong>and are characterized by <strong>palisading nuclei </strong>creating <strong>nuclear-free zones </strong>within the <strong>densely cellular Antoni A areas of the tumor</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1302</span></strong></span></span></p>",
    "correct_choice_id": 62023,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15503,
    "choices": [
      {
        "id": 61972,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocytic astrocytoma</span></span></span></p>"
      },
      {
        "id": 61973,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glioblastoma</span></span></span></p>"
      },
      {
        "id": 61974,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medulloblastoma</span></span></span></p>"
      },
      {
        "id": 61975,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ependymoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 9-year-old child presents with headaches and ataxia. Imaging reveals a cerebellar tumor with characteristic histological features, including the presence of eosinophilic, corkscrew-shaped protein aggregates known as Rosenthal fibers. Which of the following tumors is most likely responsible for these histopathological findings?</span></span></p>",
    "unique_key": "Q5109577",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088027,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Pilocytic astrocytoma </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocytic astrocytomas</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>low-grade gliomas </strong>that commonly occur in the <strong>cerebellum of children and young adults</strong>. These <strong>tumors </strong>are characterized by the <strong>presence of Rosenthal fibers</strong>, which are <strong>eosinophilic</strong>, <strong>corkscrew-shaped protein aggregates</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glioblastomas</strong> are <strong>high-grade tumors </strong>that can have <strong>various cellular morphologies </strong>but do not typically have Rosenthal fibers as a defining characteristic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastomas</strong> are <strong>highly malignant primitive neuroectodermal tumors </strong>commonly found in the <strong>cerebellum </strong>of <strong>children </strong>but are not associated with Rosenthal fibers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ependymomas</strong> <strong>arise </strong>from the <strong>ependymal cells </strong>of the <strong>ventricular system </strong>and can occur in the <strong>cerebellum</strong>, but they are not characterized by the presence of Rosenthal fibers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pilocytic astrocytoma </strong>is most likely responsible for the <strong>histopathological </strong>findings of <strong>eosinophilic</strong>, <strong>corkscrew-shaped Rosenthal fibers</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1293</span></strong></span></span></p>",
    "correct_choice_id": 61972,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15501,
    "choices": [
      {
        "id": 61964,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung </span></span></span></p>"
      },
      {
        "id": 61965,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver</span></span></span></p>"
      },
      {
        "id": 61966,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spleen </span></span></span></p>"
      },
      {
        "id": 61967,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CNS</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a pediatric patient diagnosed with a primitive neuroectodermal tumor of the cerebellum (medulloblastoma) , known for its aggressive nature and potential for metastasis, which anatomical site would be the most vigilant for the detection of metastatic spread?</span></span></p>",
    "unique_key": "Q4245861",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088028,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) CNS</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastomas </strong>have a <strong>propensity to spread to the subarachnoid space</strong>. <strong>Dissemination </strong>through the <strong>CSF is a common complication</strong>, giving rise to either <strong>extensive growth </strong>along the <strong>surface likened to &ldquo;icing,&rdquo; </strong>or <strong>nodular &ldquo;drop metastases,&rdquo; </strong>which tend to involve the <strong>cauda equina</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>most commonly <strong>metastasizes </strong>within the <strong>central nervous system </strong>(CNS) , <strong>spreading </strong>through the <strong>CSF to create &quot;drop metastases&quot; </strong>particularly at the <strong>cauda equina</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1298</span></strong></span></span></p>",
    "correct_choice_id": 61967,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15500,
    "choices": [
      {
        "id": 61960,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medulla </span></span></span></p>"
      },
      {
        "id": 61961,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebellum</span></span></span></p>"
      },
      {
        "id": 61962,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebrum </span></span></span></p>"
      },
      {
        "id": 61963,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pineal gland</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old child presents with symptoms of vomiting, headache, and unsteady gait. Brain imaging reveals the diagnosis of a medulloblastoma. Which of the following is the commonest for this tumor? </span></span></p>",
    "unique_key": "Q8273491",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088029,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Cerebellum </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key points about medulloblastoma</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>children</strong>, the location is in the <strong>midline</strong> of the<strong> cerebellum</strong>, but lateral locations are more often found in adults.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medulloblastomas are the <strong><em>most common malignant brain tumor of childhood</em></strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">5% of children have it in association with <strong>Gorlin syndrome </strong>(the most common of the inherited disorders due to mutations in the patched-1; PTCH-1 gene.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histologically, there is <strong>presence of Homer-Wright rosettes. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>commonly occurs in the <strong>cerebellum </strong>, and is the <strong>most common malignant brain tumor </strong>of <strong>childhood</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1298</span></strong></span></span></p>",
    "correct_choice_id": 61961,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15493,
    "choices": [
      {
        "id": 61932,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer disease</span></span></span></p>"
      },
      {
        "id": 61933,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parkinson disease</span></span></span></p>"
      },
      {
        "id": 61934,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington disease</span></span></span></p>"
      },
      {
        "id": 61935,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pick disease</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old male presents with gait problems. On examination, a key pathological feature in the substantia nigra neurons is observed, characterized by abnormal protein aggregates primarily composed of alpha-synuclein. Which of the following conditions is most likely responsible for the presence of these intracellular inclusions?</span></span></p>",
    "unique_key": "Q9680889",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088030,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Parkinson disease </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lewy bodies </strong>are <strong>abnormal protein aggregates </strong>primarily <strong>composed of alpha-synuclein</strong>. They are <strong>commonly found in the substantia nigra neurons </strong>in <strong>Parkinson&#39;s disease</strong>, contributing to the <strong>neurodegenerative process</strong>. These intracellular inclusions are a hallmark of Parkinson&#39;s disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>Alzheimer&#39;s disease </strong>may <strong>involve abnormal protein aggregates</strong>, including <strong>beta-amyloid plaques </strong>and <strong>neurofibrillary tangles</strong>, Lewy bodies are not characteristic of Alzheimer&#39;s disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Huntington&#39;s disease </strong>is characterized by the <strong>presence of huntingtin protein aggregates </strong>but not Lewy bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pick&#39;s disease </strong>is associated with <strong>frontotemporal lobar degeneration </strong>and is characterized by <strong>Pick bodies</strong>, not Lewy bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Parkinson disease </strong>is most likely responsible for the <strong>presence of these intracellular inclusions</strong>, as <strong>Lewy bodies composed of alpha-synuclein </strong>are a hallmark of this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1282</span></strong></span></span></p>",
    "correct_choice_id": 61933,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15492,
    "choices": [
      {
        "id": 61928,
        "text": "<p><span style=\"font-size:12pt;\">Parietal and frontal lobe</span></p>"
      },
      {
        "id": 61929,
        "text": "<p><span style=\"font-size:12pt;\">Temporal and Parietal lobe</span></p>"
      },
      {
        "id": 61930,
        "text": "<p><span style=\"font-size:12pt;\">Temporal and occipital lobe</span></p>"
      },
      {
        "id": 61931,
        "text": "<p><span style=\"font-size:12pt;\">Parietal and occipital lobe</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is affected in patients with Alzheimer\u2019s disease?</span></p>",
    "unique_key": "Q9368123",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088031,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Temporal and Parietal lobe</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Grossly</strong>, the <strong>brain shows a variable degree of cortical atrophy </strong>marked by <strong>widening of the cerebral sulci </strong>that is most pronounced in the <strong>frontal, temporal, and parietal lobes</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Hippocampus&nbsp;</strong>and other medial temporal lobe structures are the <strong>earliest</strong> and <strong>most severely affected</strong> in Alzheimer\u2019s disease.</span></li><li><span style=\"font-size:12pt;\">Bradley\u2019s Neurology mentions that.. \u201ccortical atrophy is most pronounced in the temporal and parietal lobe with the frontal lobe involvement being later in the disease\u201d.</span></li><li><span style=\"font-size:12pt;\">The <strong>parietal and temporal lobes</strong> are the <strong>areas most prominently affected in Alzheimer\u2019s disease</strong>. The <strong>hippocampus</strong>, located in the <strong>medial temporal lobe</strong>, is particularly known for <strong>showing early atrophy</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Temporal lobe:</strong> especially the hippocampus: Involved in memory formation and learning. Early Alzheimer\u2019s often presents with short-term memory loss due to hippocampal involvement.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Parietal lobe:</strong> Involved in spatial orientation, language, and navigation. As the disease progresses, patients may show visuospatial deficits and language disturbances.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong> While the <strong>parietal and frontal lobes </strong>may be <strong>affected later in Alzheimer\u2019s disease</strong>, they are not typically the regions most affected early in the disease process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Temporal lobe </strong>involvement is a <strong>hallmark of Alzheimer's disease</strong>, but the occipital lobe is generally spared until the later stages of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong> The <strong>occipital lobe</strong>, involved in <strong>visual processing</strong>, is typically <strong>less affected </strong>than the <strong>parietal and temporal lobes </strong>in Alzheimer\u2019s disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In <strong>Alzheimer\u2019s disease</strong>, <strong>atrophy </strong>is most <strong>pronounced in the parietal </strong>and <strong>temporal lobes</strong>, which includes the <strong>hippocampus</strong>, one of the earliest and most severely affected areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbin 10<sup>th</sup>/ 1275</strong></span></p>",
    "correct_choice_id": 61929,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15490,
    "choices": [
      {
        "id": 61920,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Syncytial </span></span></span></p>"
      },
      {
        "id": 61921,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibroblastic</span></span></span></p>"
      },
      {
        "id": 61922,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic </span></span></span></p>"
      },
      {
        "id": 61923,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atypical</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old female presents with a history of progressively worsening headaches and focal neurological deficits. Brain imaging reveals an enhancing mass which on histopathological examination confirms the diagnosis of meningioma. Which subtype of meningioma is associated with the worst prognosis?</span></span></p>",
    "unique_key": "Q1082261",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088032,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Anaplastic </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Meningiomas </strong>are <strong>classified into different subtypes </strong>based on their <strong>histological features</strong>. Among these, <strong>anaplastic meningiomas </strong>have the <strong>worst prognosis</strong>. <strong>Anaplastic meningiomas </strong>are characterized by a <strong>higher degree of cellular atypia </strong>and <strong>increased mitotic activity</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Syncytial</strong> <strong>meningiomas </strong>are characterized by <strong>densely packed cells </strong>with <strong>minimal intervening connective tissue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fibroblastic</strong> <strong>meningiomas </strong>are composed of <strong>spindle-shaped cells </strong>resembling fibroblasts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atypical</strong> <strong>meningiomas </strong>are <strong>intermediate </strong>in terms of <strong>aggressiveness between benign </strong>and <strong>anaplastic meningiomas</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anaplastic meningioma </strong>is associated with the <strong>worst prognosis </strong>among the <strong>meningioma subtypes </strong>due to its <strong>high degree of cellular atypia </strong>and <strong>increased mitotic activity</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> /1301</span></strong></span></span></p>",
    "correct_choice_id": 61922,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15482,
    "choices": [
      {
        "id": 61888,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin</span></span></span></span></p>"
      },
      {
        "id": 61889,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine</span></span></span></span></p>"
      },
      {
        "id": 61890,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GABA (Gamma-aminobutyric acid)</span></span></span></span></p>"
      },
      {
        "id": 61891,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old male presents with a resting tremor, bradykinesia, and rigidity. On examination, there is a characteristic &quot;pill-rolling&quot; tremor observed. The patient also exhibits postural instability. Which neurotransmitter is primarily affected in the pathophysiology of Parkinson&#39;s disease?</span></span></p>",
    "unique_key": "Q4098651",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088033,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Parkinson&#39;s disease </strong>is a <strong>neurodegenerative disorder </strong>characterized by the <strong>degeneration of dopaminergic neurons </strong>in the <strong>substantia nigra</strong>. The <strong>loss of dopamine-producing neurons </strong>leads to the <strong>classic motor symptoms </strong>of <strong>resting tremor</strong>, <strong>bradykinesia</strong>, and <strong>rigidity</strong>. The characteristic <strong>&quot;pill-rolling&quot; tremor </strong>is often observed, and <strong>postural instability </strong>may develop as the disease progresses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Explanation</u>:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Changes </strong>in <strong>serotonin levels </strong>are more associated with <strong>mood disorders</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>imbalances in acetylcholine </strong>and <strong>dopamine </strong>play a role in <strong>movement disorders</strong>, the primary deficit in Parkinson&#39;s disease is related to dopamine deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>GABA </strong>is an <strong>inhibitory neurotransmitter</strong>, and <strong>alterations in GABAergic transmission </strong>are not the primary cause of Parkinson&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>neurotransmitter primarily affected in the pathophysiology </strong>of <strong>Parkinson&#39;s disease </strong>is <strong>Dopamine</strong>, which is <strong>depleted </strong>due to <strong>degeneration of dopaminergic neurons </strong>in the <strong>substantia nigra</strong>, leading to characteristic symptoms like <strong>resting tremor</strong>, <strong>bradykinesia, </strong>and <strong>rigidity</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1293</span></span></strong></span></span></p>",
    "correct_choice_id": 61891,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15481,
    "choices": [
      {
        "id": 61884,
        "text": "<p><span style=\"font-size:12.0pt;\">Astrocytoma</span></p>"
      },
      {
        "id": 61885,
        "text": "<p><span style=\"font-size:12.0pt;\">Medulloblastoma</span></p>"
      },
      {
        "id": 61886,
        "text": "<p><span style=\"font-size:12.0pt;\">Meningioma</span></p>"
      },
      {
        "id": 61887,
        "text": "<p><span style=\"font-size:12.0pt;\">Secondaries</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old patient presents with neurological symptoms, and imaging reveals multiple intracranial lesions. Considering all tumor types, which is the most common cause of intracranial tumors in adults?</span></p>",
    "unique_key": "Q6629599",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088034,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Secondaries</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Brain metastases </strong>or <strong>secondaries</strong>, which <strong>represent tumors </strong>that have <strong>spread to the brain from other organs</strong>, can collectively be a significant cause of <strong>intracranial tumors</strong>, especially in <strong>adults</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Secondary brain tumors</strong>, also known as <strong>metastatic brain tumors </strong>or <strong>secondaries</strong>, occur when <strong>cancer cells spread to the brain </strong>from <strong>another organ</strong>. These are the most <strong>common cause of intracranial tumors in adults</strong>, <strong>surpassing primary brain tumors </strong>in incidence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;Astrocytoma</strong>, which includes <strong>glioblastoma multiforme</strong>, is a type of <strong>primary brain tumor originating from astrocytes</strong>. They are one of the <strong>most common primary brain tumors </strong>in <strong>adults </strong>but not the most common cause of intracranial tumors when all tumor types are considered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;Medulloblastoma </strong>is a <strong>common brain tumor in children </strong>and is <strong>rarely the cause of intracranial tumors in adults</strong>, as its occurrence decreases significantly with age.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;Meningiomas </strong>are <strong>common</strong>, usually <strong>benign</strong>, <strong>primary brain tumors </strong>arising from the <strong>meninges </strong>and are <strong>more prevalent in adults</strong>, particularly in <strong>women</strong>. However, they are not the most common cause of all intracranial tumors in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Secondaries </strong>are the <strong>most common cause of intracranial tumors </strong>in <strong>adults</strong>, with <strong>metastases </strong>to the <strong>brain </strong>from other <strong>primary cancers </strong>occurring more frequently than <strong>primary brain tumors</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Common primaries that metastasize to the brain: lung, breast, melanoma, kidney, and colon.</span></li><li><span style=\"font-size:12.0pt;\">Often <strong>multiple lesions</strong>, located at the gray-white matter junction.</span></li><li><span style=\"font-size:12.0pt;\">Account for 40\u201350% of intracranial tumors in adults.</span></li><li><span style=\"font-size:12.0pt;\">Among <strong>primary brain tumors</strong> in adults:</span><ul><li><span style=\"font-size:12.0pt;\">Most common benign \u2192 <strong>Meningioma</strong></span></li><li><span style=\"font-size:12.0pt;\">Most common malignant \u2192 <strong>Glioblastoma multiforme (GBM, an astrocytoma subtype)</strong></span></li></ul></li></ul>",
    "correct_choice_id": 61887,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15480,
    "choices": [
      {
        "id": 61880,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiosensitive tumor</span></span></span></span></p>"
      },
      {
        "id": 61881,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spreads through CSF</span></span></span></span></p>"
      },
      {
        "id": 61882,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical treatment not done</span></span></span></span></p>"
      },
      {
        "id": 61883,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occurs in young age group</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not true about medulloblastoma?</span></span></p>",
    "unique_key": "Q3819338",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088035,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Surgical treatment not done</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>is a <strong>malignant embryonal tumor </strong>that <strong>primarily affects the cerebellum </strong>and is <strong>more common in children</strong>. <strong>Surgical intervention </strong>is a crucial <strong>component of the management of this tumor </strong>and is <strong>performed to remove </strong>as much of the <strong>tumor </strong>as possible. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>is a <strong>radiosensitive tumor </strong>and <strong>radiation therapy </strong>is often part of the treatment plan.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>commonly <strong>spreads through the cerebrospinal fluid </strong>(CSF), leading to <strong>leptomeningeal dissemination</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>predominantly occurs in the <strong>pediatric age group</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Surgical treatment </strong>is indeed <strong>performed for medulloblastoma </strong>and it is an important part of the <strong>management strategy </strong>for this type of <strong>tumor</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 1298</span></span></strong></span></span></p>",
    "correct_choice_id": 61882,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14667,
    "choices": [
      {
        "id": 58629,
        "text": "<p><span style=\"font-size:12pt;\">Polyarteritis nodosa</span></p>"
      },
      {
        "id": 58630,
        "text": "<p><span style=\"font-size:12pt;\">Systemic hypertension</span></p>"
      },
      {
        "id": 58631,
        "text": "<p><span style=\"font-size:12pt;\">Malignant hypertension</span></p>"
      },
      {
        "id": 58632,
        "text": "<p><span style=\"font-size:12pt;\">Wegeners disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 65-year-old woman complains of increased fatigue since last 2 years. Her serum creatinine and blood urea nitrogen are raised. USG shows both kidneys symmetrically reduced in size. Kidney biopsy done shows the following finding. What is the likely diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3qbCYsK.png\" width=\"557\" height=\"372\"></p>",
    "unique_key": "Q8190525",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088036,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Systemic hypertension</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This is <strong>hyaline arteriosclerosis</strong> of vessel wall seen in <strong>benign hypertension</strong> wherein the <strong>kidneys are symmetrically contracted</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Similar changes can also be seen in <strong>diabetes mellitus.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>systemic hypertension, </strong>especially <strong>long-standing and poorly controlled cases</strong>, <strong>hyaline arteriosclerosis of the vessel wall </strong>can occur, leading to symmetrically<strong> reduced kidney size</strong>. This finding is consistent with the<strong> patient\u2019s presentation and biopsy </strong>results.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Polyarteritis nodosa </strong>typically presents with <strong>vasculitis and fibrinoid necrosis </strong>on kidney biopsy. It is characterized by <strong>segmental necrotizing inflammation of medium-sized arteries, </strong>which would be evident on histological examination.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Malignant hypertension </strong>typically presents with <strong>\"flea-bitten\" kidneys </strong>on imaging and demonstrates<strong> fibrinoid necrosis </strong>on kidney biopsy. This <strong>patient's presentation, including symmetrically reduced kidney size and the absence of fibrinoid necrosis</strong>, is not consistent with malignant hypertension.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Wegener's granulomatosis </strong>is characterized by<strong> granulomatous </strong>inflammation of the vessel wall. However, the histological findings described in the<strong> patient's kidney biopsy do not align with this diagnosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Symmetrically reduced kidney size </strong>with<strong> hyaline arteriosclerosis </strong>of the vessel wall is indicative of <strong>systemic hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Onion-skinning of blood vessels in kidney is seen in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Malignant hypertension</span></li><li><span style=\"font-size:16px;\">Chronic transplant rejection</span></li><li><span style=\"font-size:16px;\">Thrombotic microangiopathies (e.g., HUS, TTP)</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ p492)</strong></span></p>",
    "correct_choice_id": 58630,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14676,
    "choices": [
      {
        "id": 58665,
        "text": "<p><span style=\"font-size:12pt;\">Proliferative endarteritits</span></p>"
      },
      {
        "id": 58666,
        "text": "<p><span style=\"font-size:12pt;\">Necrotizing arteriolitis</span></p>"
      },
      {
        "id": 58667,
        "text": "<p><span style=\"font-size:12pt;\">Hyaline arteriolosclerosis</span></p>"
      },
      {
        "id": 58668,
        "text": "<p><span style=\"font-size:12pt;\">Cystic medial necrosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following is the commonest histological finding in benign hypertension?&nbsp;<i>&nbsp;</i></span></p>",
    "unique_key": "Q6899283",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088037,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Hyaline arteriolosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture20.jpg\" alt=\"\" width=\"1000\" height=\"272\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;Proliferative endarteritis</strong> is <strong>not </strong>the most common finding in <strong>benign hypertension. </strong>It involves <strong>inflammation and hyperplasia of the intima (inner layer) of arteries</strong>, often seen in conditions like vasculitis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Necrotizing arteriolitis </strong>involves <strong>necrosis of the arterioles,</strong> and while it can occur in severe forms of <strong>hypertension,</strong> it is <strong>not </strong>the most common histological finding in<strong> benign hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.&nbsp;Cystic medial necrosis </strong>is associated with conditions like <strong>Marfan syndrome </strong>and is characterized by <strong>degeneration and cystic</strong> changes in the<strong> arterial media</strong>. It is<strong> not </strong>a common finding in<strong> benign hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>commonest histological </strong>finding in <strong>benign hypertension </strong>is <strong>Hyaline arteriolosclerosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ p492)</strong></i></span></p>",
    "correct_choice_id": 58667,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14677,
    "choices": [
      {
        "id": 58669,
        "text": "<p><span style=\"font-size:12pt;\">Takayasu arteritis</span></p>"
      },
      {
        "id": 58670,
        "text": "<p><span style=\"font-size:12pt;\">Giant cell arteritis</span></p>"
      },
      {
        "id": 58671,
        "text": "<p><span style=\"font-size:12pt;\">Microscopic polyangiitis</span></p>"
      },
      {
        "id": 58672,
        "text": "<p><span style=\"font-size:12pt;\">Temporal arteritis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 35-year-old patient comes to the clinic with concerns of difficulty in using her right arm, especially when performing tasks like combing her hair or reaching for objects on high shelves. She also reports occasional dizziness and headaches. On examination, you notice a significant difference in blood pressure between her arms, with the right arm showing a considerably lower reading. Additionally, the patient's right radial pulse is weak compared to the left. Fundoscopic examination reveals retinal hemorrhages. Which of the following is the most likely diagnosis?</span></p>",
    "unique_key": "Q4429918",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088038,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Takayasu arteritis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Takayasu arteritis </strong>is a <strong>granulomatous vasculitis of medium- and large-sized arteries </strong>particularly affecting the<strong> aorta and its main branches. </strong>This condition is more common in<strong> young women</strong>. Its clinical features may include <strong>diminished or absent pulses</strong>, particularly in the <strong>upper extremities</strong>. This is due to<strong> inflammation and stenosis of the large vessels</strong>, leading to <strong>reduced blood flow</strong>. <strong>Ocular </strong>involvement, including <strong>retinal hemorrhages</strong>, can be a manifestation of <strong>Takayasu arteritis</strong>. The<strong> inflammation and narrowing </strong>of the vessels can affect<strong> blood flow to various organs</strong>, including the <strong>eyes</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Takayasu arteritis </strong>is a characterized princi\u00adpally by <strong>ocular disturbances </strong>and <strong>marked weakening of the pulses </strong>in the upper extremities (hence the alternate name, pulseless disease)\u2026Robbins</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Giant cell arteritis</strong> typically affects <strong>older individuals</strong> and involves <strong>inflammation of medium to large-sized arteries</strong>. It commonly presents with <strong>headaches, jaw claudication, </strong>and<strong> visual disturbances</strong> but is<strong> less </strong>associated with<strong> reduced pulses</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Microscopic polyangiitis </strong>is a <strong>small-vessel vasculitis</strong>. It often presents with <strong>renal involvement, lung disease, and skin manifestations</strong>. It is less likely to cause the characteristic findings of <strong>reduced pulses and retinal hemorrhages </strong>seen in the scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;<strong>Temporal arteritis</strong>, also known as<strong> giant cell arteritis </strong>when involving <strong>large vessels</strong>, is characterized by<strong> inflammation of medium to large arteries. </strong>While it can affect the<strong> upper limb arteries</strong>, it is more closely associated with the<strong> temporal arteries and </strong>often presents with<strong> headaches, jaw claudication, and visual disturbances.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The clinical features of <strong>Takayasu arteritis </strong>includes<strong> reduced pulses in the upper limbs and retinal hemorrhages.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> 385)</strong></span></p>",
    "correct_choice_id": 58669,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14680,
    "choices": [
      {
        "id": 58681,
        "text": "<p><span style=\"font-size:12.0pt;\">Atherosclerosis</span></p>"
      },
      {
        "id": 58682,
        "text": "<p><span style=\"font-size:12.0pt;\">Syphilis</span></p>"
      },
      {
        "id": 58683,
        "text": "<p><span style=\"font-size:12.0pt;\">Trauma</span></p>"
      },
      {
        "id": 58684,
        "text": "<p><span style=\"font-size:12.0pt;\">Congenital</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 65-year-old male smoker with a history of hypertension presents with mild abdominal discomfort and is found to have a pulsatile mass on abdominal examination. His blood pressure is well-controlled on antihypertensive medication. Which of the following is the most common cause of abdominal aortic aneurysm?&nbsp;</span></p>",
    "unique_key": "Q9234281",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088039,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Atherosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Direct quote from Harrison\u2026.\u2019<strong>atleast 90% of all abdominal aortic aneurysms &gt;4.0 cm are related to atherosclerotic disease and most are present just below the renal arteries\u2019</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>predominant </strong>cause of <strong>AAA&nbsp; </strong>is <strong>atherosclerosis, </strong>a condition characterized by the <strong>build-up of fatty deposits, cholesterol,</strong> and other <strong>substances on the walls of arteries.</strong> Over time, this leads to the formation of <strong>plaques </strong>that can<strong> weaken and damage the arterial walls.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;</strong>While <strong>syphilis </strong>can cause <strong>aortic aneurysms</strong>, it is<strong> less common </strong>in contemporary medicine due to the widespread use of <strong>antibiotics. </strong>Atherosclerosis is a more prevalent and frequent cause.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Trauma </strong>can indeed lead to <strong>aortic aneurysms</strong>, but it's generally <strong>less common </strong>than <strong>atherosclerosis </strong>as a cause. <strong>Traumatic aneurysms </strong>often result from <strong>severe injuries or accidents</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;<strong>Congenital factors </strong>can contribute to the development of <strong>aortic aneurysms</strong>, but they are <strong>less </strong>common compared to <strong>acquired conditions</strong>. <strong>Atherosclerosis </strong>is still a <strong>more prevalent</strong> cause in the <strong>adult population.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> predominant </strong>cause of <strong>abdominal aortic aneurysm is atherosclerosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 509)</strong></span></p>",
    "correct_choice_id": 58681,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14699,
    "choices": [
      {
        "id": 58757,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cell arteritis </span></span></span></p>"
      },
      {
        "id": 58758,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takayasu arteritis </span></span></span></p>"
      },
      {
        "id": 58759,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAN </span></span></p>"
      },
      {
        "id": 58760,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microscopic polyangiitis </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old man presents with a month-long history of malaise, weight loss, and renal impairment. His urinalysis shows microscopic hematuria and proteinuria. A chest X-ray reveals bilateral nodular infiltrates. Serology tests are positive for p-ANCA. Small vessels vasculitis is seen in </span></span></span></p>",
    "unique_key": "Q1047408",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088040,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Microscopic polyangiitis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microscopic polyangiitis </strong>(MPA) is a type of <strong>small-vessel vasculitis</strong>. It is characterized by <strong>inflammation of small blood vessels</strong>, including <strong>capillaries</strong>, <strong>venules</strong>, and <strong>arterioles</strong>. <strong>MPA </strong>is often associated with the <strong>presence of antineutrophil cytoplasmic antibodies </strong>(ANCA) and primarily <strong>affects the kidneys and lungs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Giant Cell Arteritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cell arteritis is primarily a <strong>large- and medium-sized vessel vasculitis</strong>. It typically involves large arteries such as the temporal arteries.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Takayasu Arteritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takayasu arteritis is a <strong>large-vessel vasculitis </strong>that <strong>affects the aorta </strong>and its <strong>major branches</strong>. It usually involves the large vessels rather than the small vessels.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Polyarteritis Nodosa (PAN):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyarteritis nodosa is a <strong>medium-sized vessel vasculitis </strong>that <strong>affects multiple organs</strong>. It is not typically considered a small-vessel vasculitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is a <strong>small-vessel vasculitis </strong>commonly <strong>associated with p-ANCA</strong>, involving the <strong>kidneys and lungs</strong>, which aligns with the patient&#39;s presentation of <strong>renal impairment</strong>, <strong>pulmonary nodules</strong>, and <strong>positive serology</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 513) </span></span></em></strong></p>",
    "correct_choice_id": 58760,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14684,
    "choices": [
      {
        "id": 58697,
        "text": "<p><span style=\"font-size:12pt;\">Henoch-Schonlein Purpura</span></p>"
      },
      {
        "id": 58698,
        "text": "<p><span style=\"font-size:12pt;\">Wegner\u2019s granulomatosis</span></p>"
      },
      {
        "id": 58699,
        "text": "<p><span style=\"font-size:12pt;\">Giant cell Vasculitis</span></p>"
      },
      {
        "id": 58700,
        "text": "<p><span style=\"font-size:12pt;\">Kawasaki\u2019s disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 5\u2011year\u2011old child presents with perivascular IgA deposition and neutrophilic collection. There is erythematous rash on the lower limbs and non-blanching purpura. The likely diagnosis in the child is:</span></p>",
    "unique_key": "Q4817766",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088041,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Henoch-Schonlein Purpura</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>HSP </strong>is a <strong>small-vessel vasculitis </strong>that commonly occurs in <strong>children</strong>. It is characterized by <strong>perivascular IgA deposition</strong>,<strong> neutrophilic infiltration, </strong>and involvement of<strong> small blood vessels</strong>. Skin manifestations often include a<strong> rash on the lower limbs</strong>, which may be <strong>erythematous and have non-blanching purpura.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Wegener's Granulomatosis: </strong>Wegener's granulomatosis is a form of <strong>granulomatosis with polyangiitis (GPA</strong>), which primarily affects the<strong> upper and lower respiratory tracts and kidneys</strong>. It is not typically associated with IgA deposition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Giant Cell Vasculitis: </strong>Giant cell vasculitis, such as <strong>giant cell arteritis</strong>, usually occurs in <strong>older </strong>individuals and involves<strong> large and medium-sized arteries</strong>. It is<strong> not </strong>commonly seen in <strong>children </strong>and does not present with the characteristic skin findings described.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Kawasaki's Disease: </strong>Kawasaki's disease is a<strong> vasculitis </strong>that affects <strong>medium-sized vessels</strong>, particularly the <strong>coronary arteries. </strong>While it can present with a<strong> rash</strong>, it is <strong>not </strong>associated with <strong>perivascular IgA deposition</strong>, which is a characteristic feature of <strong>HSP.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Henoch-Sch\u00f6nlein purpura (HSP) </strong>is a<strong> small-vessel vasculitis </strong>that most commonly occurs in<strong> children </strong>and is characterized by a<strong> tetrad of palpable purpura, abdominal pain, arthralgia, and renal involvement. </strong>It is often preceded by an <strong>upper respiratory tract infection </strong>and is associated with<strong> IgA immune complex deposition in the affected vessels.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 561)</strong></i></span></p>",
    "correct_choice_id": 58697,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14686,
    "choices": [
      {
        "id": 58705,
        "text": "<p><span style=\"font-size:12pt;\">Wegener\u2019s granulomatosis</span></p>"
      },
      {
        "id": 58706,
        "text": "<p><span style=\"font-size:12pt;\">Buerger\u2019s disease</span></p>"
      },
      {
        "id": 58707,
        "text": "<p><span style=\"font-size:12pt;\">Takayasu\u2019s arteritis</span></p>"
      },
      {
        "id": 58708,
        "text": "<p><span style=\"font-size:12pt;\">Microscopic polyangiitis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In the evaluation of a patient with systemic vasculitis, which of the following conditions is least likely to show granulomatous inflammation on biopsy?</span></p>",
    "unique_key": "Q4405981",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088042,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) Microscopic polyangiitis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D:&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Microscopic polyangiitis </strong>does <strong>not </strong>involve <strong>granulomatous inflammation</strong>; rather, it is <strong>associated with necrotizing inflammation </strong>that <strong>affects small vessels</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">It is MPO-ANCA positive vasculitis disorder, characterized by pauci-immune glomerulonephritis and pulmonary capillaritis.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong> <strong>Wegener's granulomatosis</strong>, now referred to as Granulomatosis with polyangiitis is known for <strong>necrotizing granulomatous inflammation</strong>, particularly affecting the respiratory tract and the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">c-ANCA positive (PR3-ANCA)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:&nbsp;Buerger\u2019s disease </strong>is characterized by <strong>granulomatous inflammation </strong>of <strong>small- and medium-sized arteries </strong>and <strong>veins </strong>in the extremities, especially in smokers</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Associated with segmental thrombosing vasculitis with microabscesses and granulomatous inflammation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:&nbsp;Takayasu\u2019s arteritis </strong>exhibits <strong>granulomatous inflammation of large vessels</strong>, particularly the aorta and its major branches.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Granulomatous thickening of the vessel wall, often leading to \"pulseless disease\"</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>MPA </strong>is a <strong>type of small-vessel vasculitis </strong>associated with <strong>necrotizing inflammation without granuloma formation</strong>, distinguishing it from the other options that are characterized by <strong>granulomatous inflammation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 513)</strong></span></p>",
    "correct_choice_id": 58708,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14701,
    "choices": [
      {
        "id": 58765,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skin and nose </span></span></p>"
      },
      {
        "id": 58766,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung and kidney </span></span></p>"
      },
      {
        "id": 58767,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart and kidney </span></span></p>"
      },
      {
        "id": 58768,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kidney and nervous system </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common organs involved in Wegener&rsquo;s granulo&shy;matosis are: </span></span></span></p>",
    "unique_key": "Q1329470",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088043,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Lung and kidney </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wegener&#39;s granulomatosis</strong>, now known as <strong>Granulomatosis with Polyangiitis </strong>(GPA), is characterized by <strong>necrotizing granulomatous inflammation </strong>affecting the <strong>respiratory tract </strong>(nose, sinuses, and lungs) and <strong>often the kidneys</strong>. It is associated with <strong>PR3-ANCA positivity</strong>, specifically against proteinase 3. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most <strong>common organs </strong>involved in <strong>Wegener&rsquo;s granulo&shy;matosis </strong>are <strong>lung and kidney</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 514) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
    "correct_choice_id": 58766,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14702,
    "choices": [
      {
        "id": 58769,
        "text": "<p><span style=\"font-size:12pt;\">Pulmonary artery</span></p>"
      },
      {
        "id": 58770,
        "text": "<p><span style=\"font-size:12pt;\">Bronchial artery</span></p>"
      },
      {
        "id": 58771,
        "text": "<p><span style=\"font-size:12pt;\">Renal artery</span></p>"
      },
      {
        "id": 58772,
        "text": "<p><span style=\"font-size:12pt;\">Cerebral artery</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 45-year-old woman with severe hypertension and worsening renal function is evaluated for suspected systemic vasculitis. She has a history of intermittent claudication and abdominal pain following meals. A biopsy of a medium-sized artery in her leg shows transmural inflammation with fibrinoid necrosis. Based on her clinical presentation, Polyarteritis nodosa does not involve:</span></p>",
    "unique_key": "Q6908199",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088044,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Pulmonary artery</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Polyarteritis nodosa</strong> typically does <strong>not</strong> involve the <strong>pulmonary arteries.</strong> It tends to <strong>affect arteries</strong> supplying various <strong>organs and tissues</strong>, but the <strong>pulmonary arteries</strong> are not commonly affected.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Although large and muscular, pulmonary arteries are part of the pulmonary circulation, which is a low-pressure system distinct from the systemic arteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PAN is strictly a systemic vasculitis, the pulmonary arteries are consistently uninvolved. </span><span style=\"font-size:12pt;\">Therefore, option (a) is correct.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Polyarteritis nodosa</strong> can involve <strong>bronchial arteries</strong>. In fact, it can affect arteries throughout the body, including those supplying the respiratory system.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Polyarteritis nodosa</strong> commonly involves the <strong>renal arteries.</strong> Renal artery involvement can lead to renal ischemia and glomerulonephritis, which are characteristic features of PAN.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Polyarteritis nodosa</strong> typically does not commonly involve <strong>cerebral arteries.</strong> However, the best answer in the given question is pulmonary artery.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>polyarteritis nodosa</strong>, the <strong>pulmonary arteries </strong>are typically <strong>spared</strong>, which <strong>helps differentiate </strong>it from other <strong>systemic vasculitides</strong> that can involve the<strong> lungs</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> / 513)&nbsp;</strong></span></p>",
    "correct_choice_id": 58769,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14704,
    "choices": [
      {
        "id": 58777,
        "text": "<p><span style=\"font-size:16px;\">Granulomatosis with Polyangitis&nbsp;</span></p>"
      },
      {
        "id": 58778,
        "text": "<p><span style=\"font-size:16px;\">IgA Vasculitis&nbsp;</span></p>"
      },
      {
        "id": 58779,
        "text": "<p><span style=\"font-size:12pt;\">Microscopic polyangiitis</span></p>"
      },
      {
        "id": 58780,
        "text": "<p><span style=\"font-size:16px;\">Eosinophilic Granulomatosis with Polyangiitis&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">ANCA is seen in all except:</span></p>",
    "unique_key": "Q3883589",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088045,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. B) IgA Vasculitis&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>IgA Vasculitis </strong>is <strong>not typically </strong>associated with<strong> ANCA</strong>. It is an<strong> immune-mediated vasculitis </strong>that primarily affects <strong>small vessels </strong>and is often characterized by <strong>palpable purpura, abdominal pain, joint pain, and kidney involvement</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Antineutrophil Cytoplasmic Antibodies (ANCA) </strong>are <strong>autoantibodies </strong>that target components of <strong>neutrophils' cytoplasmic granules. ANCA-associated vasculitides (AAV) </strong>are a group of<strong> autoimmune diseases </strong>characterized by inflammation of <strong>small blood vessels</strong>. Among the options provided:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Granulomatosis with Polyangiitis (GPA): </strong>Granulomatosis with Polyangiitis is associated with PR 3ANCA (directed against proteinase 3),&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Microscopic polyangiitis: </strong>Microscopic polyangiitis is associated with MPO ANCA, directed against myeloperoxidase (MPO).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.</strong> <strong>Eosinophilic Granulomatosis with Polyangiitis (EGPA):&nbsp;</strong> Eosinophilic Granulomatosis with Polyangiitis is associated with MPO ANCA directed against myeloperoxidase (MPO).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Antineutrophil cytoplasmic antibodies (ANCA) are not seen with IgA Vasculitis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 512)</strong></span></p>",
    "correct_choice_id": 58778,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14728,
    "choices": [
      {
        "id": 58873,
        "text": "<p><span style=\"font-size:12.0pt;\">Rash</span></p>"
      },
      {
        "id": 58874,
        "text": "<p><span style=\"font-size:12.0pt;\">Lymph node</span></p>"
      },
      {
        "id": 58875,
        "text": "<p><span style=\"font-size:12.0pt;\">Cardiac involvement</span></p>"
      },
      {
        "id": 58876,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombrocytosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 3-year-old boy presents with high fever for five days, bilateral nonexudative conjunctivitis, red cracked lips, a strawberry tongue, and swelling of the hands and feet. The child appears irritable, and his mother mentions a rash that developed over his trunk and extremities. Most dreadful complication of Kawasaki\u2019s disease is:</span></p>",
    "unique_key": "Q4937355",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088046,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Cardiac involvement</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Kawasaki disease,</strong>&nbsp;It is a<strong> systemic vasculitis </strong>that primarily affects <strong>children</strong>. The classic features include <strong>prolonged fever</strong>, <strong>mucocutaneous involvement (such as the strawberry tongue and erythematous rash), and cervical lymphadenopathy</strong>. If<strong> untreated, </strong>Kawasaki disease can lead to <strong>coronary artery involvement </strong>and potentially <strong>serious complications</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cardiac involvement, specifically<strong> coronary artery aneurysms</strong>, is the<strong> most </strong>severe complication of <strong>Kawasaki disease </strong>and can have <strong>long-term cardiovascular implications</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong> While<strong> rash </strong>is a common feature of<strong> Kawasaki disease</strong>, it is <strong>not </strong>typically associated with the most serious complications.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Lymph node enlargement </strong>can be a feature of <strong>Kawasaki disease </strong>but is not considered the most severe complication.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Thrombocytosis </strong>is common in the<strong> second week </strong>of illness in<strong> Kawasaki disease </strong>and typically resolves; it is<strong> not </strong>the most feared complication.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">When treating <strong>Kawasaki disease</strong>, <strong>close monitoring </strong>for cardiac complications, such as <strong>coronary artery aneurysms</strong>, is critical due to the risk of <strong>serious outcomes like myocardial infarction or sudden death</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Robbins 10<sup>th</sup> 512)</strong></i></span></p>",
    "correct_choice_id": 58875,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14742,
    "choices": [
      {
        "id": 58929,
        "text": "<p><span style=\"font-size:12pt;\">C- reactive protein</span></p>"
      },
      {
        "id": 58930,
        "text": "<p><span style=\"font-size:12pt;\">Anti- proteinase 3</span></p>"
      },
      {
        "id": 58931,
        "text": "<p><span style=\"font-size:12pt;\">Cryoglobulin</span></p>"
      },
      {
        "id": 58932,
        "text": "<p><span style=\"font-size:12pt;\">Platelet count</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which laboratory test parameter can indicate the highest relative risk for developing atherosclerosis?</span></p>",
    "unique_key": "Q3430486",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088047,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) C- reactive protein</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>C-reactive protein (CRP)</strong> is an <strong>inflammatory marker </strong>that when<strong> elevated</strong>, indicates<strong> endothelial cell activation </strong>and is associated with the development of<strong> atherosclerosis and cardiovascular risk.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>C- reactive protein (CRP) </strong>is an <strong>acute phase reactant </strong>that causes <strong>endothelial cell activation, </strong>promote <strong>thrombosis and increases leukocyte adhesiveness </strong>in developing <strong>atheromas.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It is an<strong> independent predictor </strong>of CV risk.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Anti-proteinase 3 (PR3)</strong> is an <strong>antibody </strong>associated with<strong> vasculitis</strong>, specifically <strong>granulomatosis with polyangiitis</strong>, and is <strong>not </strong>a direct marker for <strong>atherosclerosis risk.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Cryoglobulins</strong> are<strong> immunoglobulins </strong>that precipitate in the <strong>cold </strong>and are associated with <strong>cryoglobulinemic vasculitis </strong>but are not direct indicators of atherosclerotic risk.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Platelet count</strong> can reflect<strong> thrombotic risk </strong>but is<strong> not an independent predictor of atherosclerosis or cardiovascular disease</strong> like<strong> CRP.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>CRP </strong>is an <strong>acute-phase reactant </strong>that, when <strong>elevated</strong>, suggests <strong>systemic inflammation </strong>and is an <strong>independent risk factor </strong>for <strong>atherosclerosis and subsequent cardiovascular events</strong>.</span></p>",
    "correct_choice_id": 58929,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14744,
    "choices": [
      {
        "id": 58937,
        "text": "<p><span style=\"font-size:12.0pt;\">Pancarditis</span></p>"
      },
      {
        "id": 58938,
        "text": "<p><span style=\"font-size:12.0pt;\">Arthritis</span></p>"
      },
      {
        "id": 58939,
        "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous nodules</span></p>"
      },
      {
        "id": 58940,
        "text": "<p><span style=\"font-size:12.0pt;\">Elevated ESR</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which one of the following is not included as major criteria in Jones criteria?</span></p>",
    "unique_key": "Q1892531",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088048,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Elevated ESR</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> Jones </strong>criteria are used for the diagnosis of<strong> rheumatic fever</strong>. The major criteria include:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pancarditis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Arthritis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Subcutaneous nodules</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Sydenham chorea</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Erythema marginatum&nbsp;</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Elevated ESR (Erythrocyte Sedimentation Rate) </strong>is <strong>not </strong>a <strong>major criterion </strong>in the Jones criteria. While it can support the <strong>diagnosis of rheumatic fever </strong>as it indicates<strong> inflammation, </strong>it is <strong>not specific </strong>and is considered a minor criterion.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Pancarditis </strong>is a major criterion in the <strong>Jones criteria</strong>. It encompasses <strong>inflammation of the entire heart</strong>, including the <strong>endocardium, myocardium, and pericardium.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> Arthritis, specifically<strong> migratory polyarthritis, </strong>is a <strong>major criterion </strong>of the <strong>Jones criteria</strong>, typically affecting <strong>large joints.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Subcutaneous nodules</strong> are also a <strong>major criterion</strong> in the <strong>Jones criteria</strong>, though they are<strong> less common. </strong>They are <strong>firm,</strong> <strong>painless, and found over bones or tendons.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> Jones criteria</strong> for the <strong>diagnosis of rheumatic fever </strong>include major criteria such as <strong>pancarditis, arthritis, subcutaneous nodules</strong>, <strong>Sydenham chorea, and erythema marginatum. Elevated ESR</strong>, while indicative of <strong>inflammation, </strong>is <strong>not</strong> a major criterion and is <strong>used</strong> as a <strong>minor or supportive criterion</strong> in the <strong>diagnosis of rheumatic fever.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 562)</strong></i></span></p>",
    "correct_choice_id": 58940,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14746,
    "choices": [
      {
        "id": 58945,
        "text": "<p><span style=\"font-size:12pt;\">Infective endocarditis</span></p>"
      },
      {
        "id": 58946,
        "text": "<p><span style=\"font-size:12pt;\">Libman Sacks endocarditis</span></p>"
      },
      {
        "id": 58947,
        "text": "<p><span style=\"font-size:12pt;\">Rheumatic heart disease</span></p>"
      },
      {
        "id": 58948,
        "text": "<p><span style=\"font-size:12pt;\">Rheumatoid heart disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Most friable vegetation is seen in:</span></p>",
    "unique_key": "Q3294443",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088049,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Infective endocarditis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/20/picture2.jpg\" alt=\"\" width=\"1000\" height=\"547\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most <strong>friable vegetations</strong>, which are indicative of a<strong> high risk of embolization</strong>, are seen in<strong> infective endocarditis</strong><i><strong>.</strong></i></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Friability refers to how easily a lesion breaks apart or embolizes. In cardiac vegetations, infective endocarditis (IE) is known to produce the most friable vegetations, due to their soft, necrotic, and loosely attached nature.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_I40O1Mu.png\" width=\"1016\" height=\"500\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 563)</strong></span></p>",
    "correct_choice_id": 58945,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14751,
    "choices": [
      {
        "id": 58965,
        "text": "<p><span style=\"font-size:12pt;\">Anitschkow cells</span></p>"
      },
      {
        "id": 58966,
        "text": "<p><span style=\"font-size:12pt;\">Epithelioid cells</span></p>"
      },
      {
        "id": 58967,
        "text": "<p><span style=\"font-size:12pt;\">Giant cells</span></p>"
      },
      {
        "id": 58968,
        "text": "<p><span style=\"font-size:12pt;\">Fibrinoid necrosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Aschoff bodies in rheumatic heart disease show all of the following features, except:&nbsp;<i>&nbsp;</i></span></p>",
    "unique_key": "Q6297568",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088050,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. B) Epithelioid cell</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Aschoff bodies </strong>consist of <strong>foci of swollen eosinophilic collagen </strong>surrounded by <strong>lymphocytes (primarily T cells),</strong> occasional <strong>plasma cells, and plump macrophages </strong>called <strong>Anitschkow cells </strong>(<strong>pathognomonic for rheumatic fever)</strong>. These cells are also called <strong>\u201ccaterpillar</strong> <strong>cells\u201d.</strong> Some of the<strong> larger macrophages</strong> become <strong>multinucleated to form Aschoff giant cells.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Epithelioid cells</strong> are characteristic of <strong>granulomatous inflammation</strong>, such as seen in <strong>tuberculosis or sarcoidosis,</strong> not in rheumatic fever.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong> <strong>Anitschkow cells </strong>are a<strong> hallmark of Aschoff bodies </strong>found in <strong>rheumatic heart disease</strong>. They are<strong> plump macrophages</strong> with a <strong>central round nucleus</strong>, giving a<strong> caterpillar-like appearance</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong> <strong>Giant cells, or Aschoff giant cells, </strong>result from the<strong> fusion </strong>of <strong>macrophages</strong> and are a feature of <strong>Aschoff bodies.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong>&nbsp;<strong>Fibrinoid necrosis</strong> is typically associated with several vasculitis as well as Rheumatic heart disease</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Aschoff bodies</strong>, pathognomonic for <strong>rheumatic fever</strong>, consist of <strong>swollen eosinophilic collagen, T cells, occasional plasma cells,</strong> <strong>Anitschkow cells, and Aschoff giant cells.</strong> <strong>Epithelioid cells </strong>are<strong> not </strong>a feature of <strong>Aschoff bodies</strong> and are instead associated with <strong>granulomatous inflammation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 561)</strong></span></p>",
    "correct_choice_id": 58966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14754,
    "choices": [
      {
        "id": 58977,
        "text": "<p><span style=\"font-size:12pt;\">Mitral valve</span></p>"
      },
      {
        "id": 58978,
        "text": "<p><span style=\"font-size:12pt;\">Aortic valve</span></p>"
      },
      {
        "id": 58979,
        "text": "<p><span style=\"font-size:12pt;\">Pulmonary valve</span></p>"
      },
      {
        "id": 58980,
        "text": "<p><span style=\"font-size:12pt;\">Tricuspid valve</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In patients with a history of intravenous drug use, which heart valve is most commonly affected by infective endocarditis?</span></p>",
    "unique_key": "Q7388792",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088051,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Tricuspid valve</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> most common heart valve </strong>involved in <strong>intravenous (IV) drug </strong>users is the <strong>tricuspid valve. Intravenous drug </strong>use can introduce <strong>bacteria into the bloodstream</strong>, leading to<strong> infections </strong>on heart valves. The <strong>tricuspid valve </strong>is particularly <strong>susceptible </strong>due to the direct <strong>flow of blood </strong>from the<strong> venous system into the right atrium and then the right ventricle</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Intravenous drug </strong>use predisposes individuals to<strong> infective endocarditis </strong>predominantly involving the <strong>tricuspid valve </strong>due to the <strong>direct flow of potentially infected blood </strong>from<strong> venous circulation to the right side of the heart</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Common Sites of Involvement in IE:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_kke98Lh.png\" width=\"931\" height=\"202\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> 563)</strong></span></p>",
    "correct_choice_id": 58980,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14760,
    "choices": [
      {
        "id": 59001,
        "text": "<p><span style=\"font-size:12.0pt;\">Blue</span></p>"
      },
      {
        "id": 59002,
        "text": "<p><span style=\"font-size:12.0pt;\">White</span></p>"
      },
      {
        "id": 59003,
        "text": "<p><span style=\"font-size:12.0pt;\">Yellow</span></p>"
      },
      {
        "id": 59004,
        "text": "<p><span style=\"font-size:12pt;\">Brick red</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">During autopsy of a patient died due to suspected myocardial infarction, the heart was stained with triphenyl tetrazolium tetra-chloride dye. What will be the color of the viable myocardium?</span></p>",
    "unique_key": "Q5433311",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088052,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Brick red&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/22/picture4.jpg\" alt=\"\" width=\"1000\" height=\"342\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This is the correct answer.<strong> Brick red </strong>coloration indicates <strong>viable myocardium </strong>when using <strong>TTC staining. </strong>Intact,<strong> noninfarcted myocardium </strong>contains enzymes like<strong> lactate dehydrogenase </strong>that reduce <strong>TTC to formazan, </strong>which has a <strong>brick-red color</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Blue is not </strong>the color associated with <strong>TTC staining</strong>. TTC is not a blue dye and does not produce a blue color in tissue staining.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;White </strong>is the color that indicates an i<strong>nfarct on TTC staining </strong>because the <strong>enzyme activity </strong>necessary to convert <strong>TTC into a red dye </strong>is <strong>lost </strong>in the infarcted area <strong>due to cell death</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Yellow </strong>is <strong>not </strong>a typical result of<strong> TTC staining </strong>in either<strong> viable or non-viable myocardial tissue.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>TTC staining </strong>during <strong>autopsy, viable myocardium</strong> is indicated by a<strong> brick-red color,</strong> which results from the <strong>presence of active dehydrogenase enzymes </strong>that <strong>reduce the TTC dye</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup> 546)</strong></i></span></p>",
    "correct_choice_id": 59004,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14762,
    "choices": [
      {
        "id": 59009,
        "text": "<p><span style=\"font-size:12.0pt;\">Myxoma</span></p>"
      },
      {
        "id": 59010,
        "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
      },
      {
        "id": 59011,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibroma</span></p>"
      },
      {
        "id": 59012,
        "text": "<p><span style=\"font-size:12.0pt;\">Leiomyosarcoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Most common primary tumor of heart is which of the following?</span></p>",
    "unique_key": "Q9638328",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088053,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Myxoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most common<strong> primary tumor of the heart is a myxoma</strong>. Myxomas are typically <strong>benign tumors </strong>that most commonly arise in the <strong>atria of the heart</strong>. They are often found in the <strong>left atrium </strong>and can cause symptoms such as <strong>obstruction of blood flow, </strong>leading to issues like <strong>syncope and heart failure</strong>. <strong>Myxomas </strong>are composed of <strong>stellate or plump cells </strong>within a<strong> myxoid stroma</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Myxoma </strong>is indeed the most common<strong> primary tumor of the heart</strong>. These<strong> benign tumors </strong>are often found in the<strong> left atrium </strong>and can cause<strong> obstructive symptoms affecting blood flow</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Rhabdomyosarcoma </strong>is a type of <strong>malignant soft tissue tumor </strong>that can occur in the<strong> heart</strong>, but it is not the most common primary cardiac tumor.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Fibroma </strong>is another type of<strong> benign cardiac tumor </strong>that typically occurs in <strong>children</strong>. While it can be found in the heart, it is not as common as myxoma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Leiomyosarcoma </strong>is a <strong>malignant tumor of smooth muscle cells. </strong>It is rare in the heart and is not the most common primary cardiac tumor.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most common <strong>primary tumor of the heart is a myxoma</strong>, which is a<strong> benign growth </strong>that most commonly arises in the <strong>atria, particularly the left atrium</strong>, and can lead to symptoms related to<strong> blood flow obstruction.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>&nbsp;(Ref: Robbins 10<sup>th</sup>/579)</strong></i></span></p>",
    "correct_choice_id": 59009,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16225,
    "choices": [
      {
        "id": 64860,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased insulin release</span></span></span></span></p>"
      },
      {
        "id": 64861,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steatosis</span></span></span></span></p>"
      },
      {
        "id": 64862,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocyte dysfunction</span></span></span></span></p>"
      },
      {
        "id": 64863,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased &lsquo;C&rsquo; peptide level</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the primary contributor to insulin resistance in liver disease?</span></span></p>",
    "unique_key": "Q6672051",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088054,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Steatosis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>accumulation of fat in the liver</strong>, or <strong>hepatic steatosis</strong>, is closely associated with <strong>insulin resistance</strong>. It <strong>impairs the liver&#39;s response </strong>to <strong>insulin</strong>, particularly affecting the <strong>inhibition of gluconeogenesis </strong>and <strong>increasing insulin resistance </strong>in <strong>peripheral tissues</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Decreased insulin release:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This refers to a <strong>problem with insulin secretion </strong>from the <strong>pancreas</strong>, not resistance at the level of hepatic or peripheral tissues and does not directly relate to liver disease.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatocyte dysfunction:</strong> While <strong>hepatocyte dysfunction </strong>can contribute to <strong>metabolic disturbances</strong>, it is a broader term that includes various liver impairments, not specific to insulin resistance.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased &lsquo;C&rsquo; peptide level:</strong> <strong>C-peptide </strong>is a <strong>byproduct of insulin production</strong>. <strong>Lower levels </strong>may indicate <strong>reduced insulin secretion </strong>but are not a direct cause of insulin resistance in the liver.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatic steatosis</strong>, or <strong>fatty liver disease</strong>, is a significant <strong>contributor to insulin resistance</strong>, which <strong>impairs both the liver&#39;s response </strong>to <strong>insulin </strong>and the <strong>peripheral action of insulin</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbin 10th/ 1140, Joslin&rsquo;s Diabetes Mellitus 14/e p436</span></span></strong></span></span></p>",
    "correct_choice_id": 64861,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16228,
    "choices": [
      {
        "id": 64872,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gastrinoma </span></span></span></span></p>"
      },
      {
        "id": 64873,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulinoma</span></span></span></span></p>"
      },
      {
        "id": 64874,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lipoma </span></span></span></span></p>"
      },
      {
        "id": 64875,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucagonoma</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common association in MEN I is?</span></span></span></span></p>",
    "unique_key": "Q8708349",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088055,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Gastrinoma </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gastrinomas</strong>, which <strong>secrete gastrin</strong>, are among the <strong>most common functional pancreatic endocrine tumors </strong>associated with <strong>MEN I </strong>and can <strong>lead to Zollinger-Ellison syndrome</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Insulinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulinomas are also <strong>associated with MEN I </strong>and result in <strong>hypoglycemia </strong>due to <strong>unregulated insulin secretion</strong>, but they are <strong>less common </strong>compared to gastrinomas.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipoma</strong>: While patients with <strong>MEN I may develop non-endocrine tumors </strong>like <strong>lipomas</strong>, these are not as commonly associated with the syndrome as endocrine tumors.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucagonoma</strong>: Glucagonomas, which <strong>secrete glucagon</strong>, are <strong>rare pancreatic endocrine tumors </strong>and are less commonly associated with MEN I than gastrinomas.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of <strong>MEN I</strong>, <strong>gastrinomas </strong>are the <strong>most commonly associated functional pancreatic endocrine tumors</strong>, often leading to <strong>Zollinger-Ellison syndrome</strong>, characterized by <strong>peptic ulcer disease</strong>, <strong>gastroesophageal reflux</strong>, and <strong>diarrhea </strong>due to <strong>hypergastrinemia</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1140</span></span></strong></span></span></p>",
    "correct_choice_id": 64872,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16229,
    "choices": [
      {
        "id": 64876,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha cell tumor</span></span></span></span></p>"
      },
      {
        "id": 64877,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most of them are malignant</span></span></span></span></p>"
      },
      {
        "id": 64878,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C-peptide level is elevated</span></span></span></span></p>"
      },
      {
        "id": 64879,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is not associated with MEN 1 syndrome</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True about insulinoma is:</span></span></p>",
    "unique_key": "Q2312590",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088056,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) C-peptide level is elevated</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>correct</strong>. <strong>Insulinomas </strong>cause <strong>increased production of insulin</strong>, and because <strong>C-peptide </strong>is <strong>co-released with insulin</strong>, its levels are also elevated.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha cell tumor:</strong> This is incorrect; <strong>insulinomas arise from beta cells </strong>of the <strong>pancreas</strong>, which are responsible for the production of insulin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Most of them are malignant:</strong> The<strong> </strong><strong>majority of insulinomas are benign</strong>; only a small percentage are malignant.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>It is not associated with MEN 1 syndrome</strong>: This is incorrect; <strong>insulinomas </strong>can be associated with <strong>Multiple Endocrine Neoplasia Type 1</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulinomas </strong>are <strong>beta-cell tumors</strong>, most of which are <strong>benign </strong>and can <strong>present with hypoglycemia </strong>and <strong>elevated levels of insulin </strong>and <strong>C-peptide in the blood</strong>. They may also be associated with <strong>MEN 1 syndrome</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1124</span></span></strong></span></span></p>",
    "correct_choice_id": 64878,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16230,
    "choices": [
      {
        "id": 64880,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromogranin-A</span></span></span></span></p>"
      },
      {
        "id": 64881,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD100</span></span></span></span></p>"
      },
      {
        "id": 64882,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CEA</span></span></span></span></p>"
      },
      {
        "id": 64883,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PSA</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What marker is indicative of a non-functional pancreatic neuroendocrine tumor (PNET)?</span></span></p>",
    "unique_key": "Q7661300",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088057,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Chromogranin-A </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chromogranin A </strong>is a <strong>protein </strong>found in the <strong>secretory vesicles of neuroendocrine cells</strong>. It is a <strong>commonly used marker </strong>for <strong>PNETs</strong>, especially when they <strong>do not secrete hormones </strong>or their secretion is not clinically apparent.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>CD100:</strong> CD100 is <strong>not a recognized marker for PNETs</strong>. CD markers are generally used in the characterization of lymphocytes and other cells of the immune system.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>CEA: </strong>Carcinoembryonic antigen (CEA) is a <strong>tumor marker associated with colorectal cancer </strong>and some other adenocarcinomas, not specifically with PNETs.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: PSA:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostate-specific antigen (PSA) is used as a <strong>marker for prostate cancer</strong>. It has no relevance in the diagnosis of PNETs.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chromogranin A </strong>is a <strong>marker for pancreatic non-functional neuroendocrine tumours</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 720</span></span></strong></span></span></p>",
    "correct_choice_id": 64880,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16234,
    "choices": [
      {
        "id": 64896,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maturity onset DM</span></span></span></span></p>"
      },
      {
        "id": 64897,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I DM</span></span></span></span></p>"
      },
      {
        "id": 64898,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II DM</span></span></span></span></p>"
      },
      {
        "id": 64899,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old male presents to the clinic with complaints of bilateral lower extremity swelling and fatigue for the past several months. He has a past medical history significant for poorly controlled diabetes mellitus, hypertension, and obesity. Laboratory investigations reveal elevated serum creatinine and proteinuria. A renal biopsy is performed, which demonstrates deposition of amyloid proteins in the glomeruli. Which of the following types of diabetes mellitus is most commonly associated with this renal complication?</span></span></span></span></p>",
    "unique_key": "Q5099913",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088058,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Type II DM </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type II DM </strong>is associated with the <strong>deposition of amyloid in the pancreatic islets</strong>, contributing to <strong>&beta;-cell dysfunction</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Maturity onset diabetes of the young </strong>(MODY) is characterized by <strong>monogenic defects of &beta;-cell function </strong>but is not typically associated with amyloid deposition in the islets.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I DM </strong>is an <strong>autoimmune disorder </strong>leading to <strong>&beta;-cell destruction </strong>and does not typically involve amyloid deposition.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amyloid deposition </strong>in the <strong>islets of Langerhans </strong>is a feature specifically associated with <strong>Type II diabetes mellitus</strong>, which can contribute to the <strong>dysfunction of insulin-secreting pancreatic &beta;-cells</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 261</span></span></strong></span></span></p>",
    "correct_choice_id": 64898,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16240,
    "choices": [
      {
        "id": 64920,
        "text": "<p><span style=\"font-size:12.0pt;\">Associated with BRAF mutation</span></p>"
      },
      {
        "id": 64921,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Psammoma body present in 50% cases</span></p>"
      },
      {
        "id": 64922,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Early metastasis with poor prognosis</span></p>"
      },
      {
        "id": 64923,
        "text": "<p><span style=\"font-size:12.0pt;\">Spreads by the lymphatic route</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">About papillary carcinoma of thyroid, all are true except:</span></p>",
    "unique_key": "Q3349935",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088059,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C) Early metastasis with poor prognosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Although <strong>papillary thyroid carcinoma </strong>can <strong>metastasize early</strong>, particularly to <strong>regional lymph nodes</strong>, it usually maintains a <strong>good prognosis </strong>and is often curable.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">This does not worsen prognosis significantly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Even with lymph node metastasis, survival remains excellent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Distant metastasis (to lungs or bone) is rare, and when present, prognosis may be slightly worse but still much better than most other cancers.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Associated with BRAF mutation:</strong> Papillary carcinoma of the thyroid is associated with BRAF gene mutation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Psammoma body present in 50% cases:</strong> Psammoma bodies are calcifications that are often found in papillary thyroid carcinoma but may not be present in as many as 50% of cases.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Spreads by the lymphatic route:</strong> This is <strong>true</strong>. Papillary thyroid carcinoma commonly spreads to regional lymph nodes via lymphatics.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">This typically involves:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Cervical lymph nodes (neck)</span></li><li><span style=\"font-size:12.0pt;\">Jugular lymph chain</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Papillary carcinoma </strong>of the <strong>thyroid </strong>typically has a <strong>favorable prognosis</strong>, even with <strong>early lymphatic spread</strong>, <strong>contrasting </strong>with other <strong>cancers </strong>where <strong>early metastasis </strong>often correlates with a <strong>poor prognosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1086</strong></span></p>",
    "correct_choice_id": 64922,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16242,
    "choices": [
      {
        "id": 64928,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia of chronic disease</span></span></span></span></p>"
      },
      {
        "id": 64929,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Proteus infection</span></span></span></span></p>"
      },
      {
        "id": 64930,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperparathyroidism</span></span></span></span></p>"
      },
      {
        "id": 64931,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperaldosteronism</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 51-year-old man Sonu with a history of recurrent calcium-containing renal stones presents to the emergency room with excruciating flank pain and blood in the urine. This patient is likely to have which of the following underlying disorders?</span></span></p>",
    "unique_key": "Q6243015",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088060,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Hyperparathyroidism </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&rsquo;s history of <strong>recurrent urolithiasis </strong>with <strong>calcium </strong>containing <strong>stones implies a disorder </strong>in the <strong>regulation of calcium concentration</strong>. <strong>Hyperparathyroidism </strong>is associated with <strong>increased PTH levels</strong>, which can <strong>produce hypercalcemia</strong>, <strong>hypercalciuria</strong>, and, ultimately, <strong>renal stones</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary hyperparathyroidism </strong>leads to <strong>elevated parathyroid hormone </strong>(PTH) <strong>levels</strong>, resulting in <strong>increased bone resorption</strong>, <strong>hypercalcemia</strong>, and <strong>hypercalciuria</strong>, which can cause<strong> calcium-containing renal stones</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anemia of chronic disease </strong>&ndash; This condition is associated with <strong>long-standing</strong>, <strong>chronic illnesses </strong>that lead to <strong>alterations in iron metabolism </strong>and <strong>erythropoiesis </strong>but is not directly related to calcium stone formation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic Proteus infection </strong>&ndash; While <strong>Proteus bacteria </strong>can <strong>increase the risk for struvite stone formation </strong>due to <strong>urease production</strong>, it is not typically associated with calcium stone formation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperaldosteronism </strong>&ndash; This condition leads to <strong>hypertension </strong>and <strong>hypokalemia </strong>due to <strong>excess aldosterone </strong>and is not typically associated with calcium-containing renal stone disease.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Recurrent calcium-containing renal stones </strong>may suggest an <strong>underlying disorder of calcium metabolism, </strong>such as <strong>hyperparathyroidism</strong>, due to its association with <strong>increased PTH levels</strong>, <strong>hypercalcemia</strong>, and <strong>hypercalciuria</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 9/e p1103</span></span></strong></span></span></p>",
    "correct_choice_id": 64930,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16243,
    "choices": [
      {
        "id": 64932,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary carcinoma </span></span></span></span></p>"
      },
      {
        "id": 64933,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hashimoto thyroiditis</span></span></span></span></p>"
      },
      {
        "id": 64934,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular cancer</span></span></span></span></p>"
      },
      {
        "id": 64935,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary cancer</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fine needle aspiration cytology is not able to detect which of the following?</span></span></p>",
    "unique_key": "Q4919929",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088061,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Follicular cancer </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC cannot differentiate between benign follicular adenomas </strong>and <strong>follicular carcinoma </strong>due to the <strong>requirement of histologic evaluation </strong>of the <strong>capsule for invasion</strong>, which is not possible with FNAC.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Papillary carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC </strong>is usually <strong>diagnostic for papillary carcinoma </strong>due to its <strong>distinctive cytological features</strong>, including <strong>nuclear grooves </strong>and <strong>psammoma bodies</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hashimoto thyroiditis:&nbsp;</strong>FNAC can suggest this <strong>diagnosis when lymphocytes </strong>and <strong>Hurthle cells are present</strong>, indicating an <strong>autoimmune process</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary cancer:</strong> <strong>FNAC </strong>can suggest <strong>medullary carcinoma </strong>by <strong>demonstrating amyloid </strong>and <strong>calcitonin in cells</strong>, but a definitive diagnosis often requires additional tests such as serum calcitonin levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>FNAC is a useful tool </strong>in the <strong>initial assessment of thyroid nodules, </strong>it <strong>cannot distinguish between follicular adenoma </strong>and <strong>follicular carcinoma </strong>due to the necessity of examining capsular and vascular invasion histologically.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 1089</span></span></strong></span></span></p>",
    "correct_choice_id": 64934,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16244,
    "choices": [
      {
        "id": 64936,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary cancer</span></span></span></span></p>"
      },
      {
        "id": 64937,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary cancer</span></span></span></span></p>"
      },
      {
        "id": 64938,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular cancer</span></span></span></span></p>"
      },
      {
        "id": 64939,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic cancer</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common thyroid cancer after radiation exposure is:</span></span></span></span></p>",
    "unique_key": "Q4142050",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088062,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Papillary cancer </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a marked <strong>increase </strong>in the <strong>incidence of papillary carcinomas </strong>among <strong>children </strong>exposed to <strong>ionizing radiation </strong>(particularly during the first 2 decades of life).</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of dietary iodine </strong>(and so, goiter) is <strong>linked with a higher frequency </strong>of <strong>follicular carcinomas</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Exposure to ionizing radiation</strong>, especially during the <strong>first two decades of life</strong>, significantly <strong>increases the risk of developing papillary thyroid carcinoma</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary cancer:</strong> Medullary thyroid cancer <strong>arises from parafollicular C-cells </strong>and is typically associated with <strong>genetic mutations in the RET proto-oncogene</strong>, not with radiation exposure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Follicular cancer:</strong> While <strong>not </strong>associated with <strong>radiation exposure</strong>, the incidence of follicular carcinoma is higher in areas with iodine deficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anaplastic cancer:</strong> Anaplastic thyroid cancer is a <strong>rare and aggressive form of thyroid cancer </strong>that generally <strong>occurs in the elderly population </strong>and is not associated with radiation exposure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Papillary thyroid carcinoma </strong>is the <strong>most common thyroid cancer </strong>associated with <strong>childhood exposure </strong>to <strong>ionizing radiation</strong>, which can significantly <strong>increase the risk of this cancer</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1086</span></span></strong></span></span></p>",
    "correct_choice_id": 64936,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16245,
    "choices": [
      {
        "id": 64940,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Papillary carcinoma thyroid</span></p>"
      },
      {
        "id": 64941,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Carcinoma pituitary</span></p>"
      },
      {
        "id": 64942,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Paraganglioma</span></p>"
      },
      {
        "id": 64943,
        "text": "<p><span style=\"font-size:12.0pt;\">Meningioma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Orphan Annie eye nuclei appearance is characteristic of:</span></p>",
    "unique_key": "Q1308372",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088063,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Papillary carcinoma thyroid</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">This <strong>thyroid cancer </strong>is noted for its <strong>unique nuclear features</strong>, which include <strong>enlarged, overlapping nuclei </strong>with <strong>finely dispersed chromatin giving an \"empty\" appearance</strong>, also known as <strong>'Orphan Annie eye' nuclei</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-094905.png\" alt=\"\" width=\"300\" height=\"211\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>'Orphan Annie eye' nuclei </strong>is a <strong>distinctive cytological feature </strong>of <strong>papillary carcinoma </strong>of the <strong>thyroid</strong>, which is important for diagnosis and distinguishing it from other neoplasms.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10th 1087</strong></span></p>",
    "correct_choice_id": 64940,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16256,
    "choices": [
      {
        "id": 64984,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary carcinoma of thyroid</span></span></span></span></p>"
      },
      {
        "id": 64985,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma breast</span></span></span></span></p>"
      },
      {
        "id": 64986,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenocarcinoma lung</span></span></span></span></p>"
      },
      {
        "id": 64987,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular carcinoma of thyroid</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old woman presents with a solitary thyroid nodule. Fine needle aspiration cytology (FNAC) is performed, and the pathologist reports that the distinction between a benign and a malignant lesion cannot be made with certainty. Which type of thyroid nodule is most notorious for requiring histologic examination beyond FNAC to establish a definitive diagnosis?</span></span></p>",
    "unique_key": "Q5883209",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088064,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Follicular carcinoma of thyroid</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC </strong>cannot distinguish <strong>between follicular adenoma</strong> and <strong>follicular carcinoma </strong>because the <strong>diagnosis of carcinoma depends on the identification of capsular and/or vascular invasion,</strong> which requires histologic examination of the surgical specimen.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Papillary carcinoma of thyroid</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Papillary carcinoma typically shows <strong>distinctive nuclear features on FNAC </strong>which are usually diagnostic, making it sufficient for diagnosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Carcinoma breast</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: FNAC can be <strong>diagnostic for breast carcinoma,</strong> showing <strong>malignant cells</strong>, but a core biopsy is often preferred for additional architectural and immunohistochemical information.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Adenocarcinoma lung</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While <strong>FNAC</strong> can suggest <strong>adenocarcinoma of the lung</strong> by demonstrating <strong>malignant glandular cells, </strong>a core biopsy is usually required for complete characterization.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>FNAC </strong>can suggest <strong>follicular neoplasm</strong>, it <strong>cannot differentiate follicular carcinoma </strong>from <strong>follicular adenoma</strong> as the <strong>latter requires the identification of capsular </strong>or <strong>vascular invasion,</strong> which necessitates histological examination of the entire surgical specimen.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1089</span></span></strong></span></span></p>",
    "correct_choice_id": 64987,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16278,
    "choices": [
      {
        "id": 65072,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exogenous corticosteroids</span></span></span></span></p>"
      },
      {
        "id": 65073,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pituitary tumor</span></span></span></span></p>"
      },
      {
        "id": 65074,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal adenoma</span></span></span></span></p>"
      },
      {
        "id": 65075,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal carcinoma</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common cause of Cushing&rsquo;s syndrome is?</span></span></p>",
    "unique_key": "Q3460802",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088065,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Exogenous corticosteroids </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>most frequent cause of Cushing&#39;s syndrome </strong>is the <strong>iatrogenic administration </strong>of <strong>exogenous corticosteroids</strong>. This can occur with <strong>prolonged use of oral</strong>, <strong>intravenous</strong>, or <strong>inhaled glucocorticoids </strong>for the <strong>treatment of various conditions </strong>such as <strong>asthma, autoimmune diseases</strong>, or after <strong>organ transplantation</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>pituitary adenoma </strong>that <strong>secretes adrenocorticotropic hormone </strong>(ACTH) can cause <strong>Cushing&#39;s disease</strong>, which is a subset of Cushing&#39;s syndrome. This is the most <strong>common cause of endogenous Cushing&#39;s syndrome</strong>, but overall less common than the exogenous form caused by taking corticosteroid medications.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>adrenal adenoma </strong>is a <strong>benign tumor </strong>of the <strong>adrenal gland </strong>that can <strong>autonomously secrete cortisol</strong>. It&#39;s a <strong>less common cause of Cushing&#39;s syndrome </strong>compared to <strong>exogenous steroid use </strong>and <strong>pituitary tumors </strong>but should be considered, especially when ACTH levels are low.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenal carcinomas </strong>are <strong>rare </strong>but can also <strong>cause Cushing&#39;s syndrome </strong>by <strong>secreting excessive amounts of cortisol</strong>. They are more aggressive than adenomas and can be associated with a worse prognosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Exogenous corticosteroids </strong>are the <strong>most common cause of Cushing&#39;s syndrome</strong>, primarily due to the <strong>widespread use of corticosteroid medications </strong>for a variety of medical conditions. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1115</span></span></strong></span></span></p>",
    "correct_choice_id": 65072,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14955,
    "choices": [
      {
        "id": 59780,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dubin-Johnson syndrome </span></span></span></span></p>"
      },
      {
        "id": 59781,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotor syndrome </span></span></span></span></p>"
      },
      {
        "id": 59782,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gilbert syndrome </span></span></span></span></p>"
      },
      {
        "id": 59783,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gall stones</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following condition is associated with unconjugated hyperbilirubinemia? </span></span><em>&nbsp;</em></p>",
    "unique_key": "Q5800156",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088066,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Gilbert syndrome </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Unconjugated hyperbilirubinemia </strong>is characterized by <strong>elevated levels of unconjugated </strong>(indirect) <strong>bilirubin </strong>in the <strong>blood</strong>. <strong>Gilbert syndrome </strong>is a common <strong>inherited condition </strong>associated with <strong>mild unconjugated hyperbilirubinemia</strong>. It results from a <strong>decreased activity </strong>of the <strong>enzyme UDP-glucuronosyltransferase</strong>, leading to <strong>impaired conjugation of bilirubin in the liver</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Dubin-Johnson syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">it is characterized by <strong>conjugated hyperbilirubinemia</strong>. It is a <strong>rare genetic disorder </strong>where there is <strong>impaired excretion </strong>of <strong>conjugated bilirubin </strong>from the liver.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Rotor syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">it is also associated with <strong>conjugated hyperbilirubinemia</strong>. It is a benign condition characterized by elevated levels of both conjugated and unconjugated bilirubin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Gall stones:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; they can <strong>lead to obstructive jaundice</strong>, causing <strong>elevated levels of both conjugated </strong>and <strong>unconjugated bilirubin</strong>. However, the primary association is with conjugated hyperbilirubinemia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gilbert syndrome </strong>is a common <strong>inherited condition </strong>associated with <strong>unconjugated hyperbilirubinemia.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 853</span></span></strong></span></span></p>",
    "correct_choice_id": 59782,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14965,
    "choices": [
      {
        "id": 59820,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berry aneurysm </span></span></span></span></p>"
      },
      {
        "id": 59821,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coronary artery aneurysm </span></span></span></span></p>"
      },
      {
        "id": 59822,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyarteritis nodosa </span></span></span></span></p>"
      },
      {
        "id": 59823,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cell arteritis</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man Bholu presents to his physician with loss of appetite, nausea and vomiting, and fatigue. Laboratory examination confirms the diagnosis of hepatitis B, and the man becomes icteric 2 weeks later. This patient may also be particularly vulnerable to the development of which of the following disorders? </span></span></p>",
    "unique_key": "Q2042994",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088067,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Polyarteritis nodosa </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thirty percent of patients </strong>with <strong>polyarteritis nodosa </strong>have <strong>hepatitis B antigenemia</strong>. <strong>Polyarteritis </strong>is a <strong>systemic necrotizing vasculitis </strong>that can be <strong>difficult to diagnose</strong>, since the <strong>vascular involvement </strong>is typically <strong>widely scattered</strong>, and the <strong>specific symptoms </strong>depend on the <strong>specific vessels </strong>(small-to medium-sized arteries) involved. Patients typically <strong>present with low-grade fever</strong>, <strong>weakness</strong>, and <strong>weight loss</strong>. <strong>Abdominal pain</strong>, <strong>hematuria</strong>, <strong>renal failure</strong>, <strong>hypertension</strong>, and <strong>leukocytosis may occur</strong>. The disease is frequently fatal if untreated. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Berry aneurysm:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A berry aneurysm is typically associated with conditions like <strong>polycystic kidney disease </strong>and <strong>hypertension</strong>, and it predominantly <strong>affects the cerebral vasculature</strong>. It is not commonly linked to hepatitis B infection.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Coronary artery aneurysm</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This type of <strong>aneurysm </strong>is often associated with <strong>Kawasaki disease </strong>or <strong>atherosclerosis</strong>, and there is <strong>no direct link to hepatitis B infection </strong>for the development of coronary artery aneurysms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Giant cell arteritis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Giant cell arteritis typically <strong>affects the large and medium arteries of older adults</strong>, particularly the temporal arteries, and is not associated with hepatitis B infection.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a <strong>well-established association between hepatitis B infection </strong>and the <strong>development of polyarteritis nodosa</strong>, a <strong>systemic necrotizing vasculitis </strong>that can <strong>affect various organ systems </strong>and can be <strong>fatal if untreated</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/ 510</span></span></strong></span></span></p>",
    "correct_choice_id": 59822,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14986,
    "choices": [
      {
        "id": 59904,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Alcoholic liver disease</span></p>"
      },
      {
        "id": 59905,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Primary biliary cirrhosis</span></p>"
      },
      {
        "id": 59906,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Secondary biliary cirrhosis</span></p>"
      },
      {
        "id": 59907,
        "text": "<p><span style=\"font-size:12.0pt;\">Indian childhood cirrhosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not associated with Mallory hyaline bodies?</span></p>",
    "unique_key": "Q7964942",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088068,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C) Secondary biliary cirrhosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Mallory bodies</strong>, also known as <strong>Mallory hyaline bodies </strong>or <strong>Mallory-Denk bodies</strong>, are <strong>abnormal intracellular inclusions </strong>found in <strong>hepatocytes</strong>. These structures are associated with <strong>various liver diseases</strong>, particularly those involving <strong>chronic hepatocellular injury</strong>. They are remembered as (New Indian Fine WATCH)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Non alcoholic fatty liver disease; NAFLD&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Indian childhood cirrhosis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Focal nodular hyperplasia</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Wilson\u2019s Disease</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Alcoholic liver disease, \u03b1-1 AT def.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Tumor (HCC)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Cholestasis (due to primary biliary cirrhosis)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Mallory-denk bodies </strong>(made up keratin 8 and 18)<strong> </strong>are associated with <strong>various liver diseases</strong>, particularly those involving <strong>chronic hepatocellular injury</strong>, but are <strong>not </strong>typically found in <strong>secondary biliary cirrhosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 843</strong></span></p>",
    "correct_choice_id": 59906,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14987,
    "choices": [
      {
        "id": 59908,
        "text": "<p><span style=\"font-size:12pt;\">Prussian blue</span></p>"
      },
      {
        "id": 59909,
        "text": "<p><span style=\"font-size:12pt;\">Alcian blue</span></p>"
      },
      {
        "id": 59910,
        "text": "<p><span style=\"font-size:12.0pt;\">Von kossa</span></p>"
      },
      {
        "id": 59911,
        "text": "<p><span style=\"font-size:12.0pt;\">Crystal violet</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 52-year-old male with a history of diabetes mellitus and joint pains presents with skin hyperpigmentation and elevated serum ferritin. A liver biopsy is performed, and the resulting slide is shown. The patient's liver biopsy is notable for a blue staining pattern within the hepatocytes. Given below is the histopathology of liver biopsy of a patient with hemochromatosis. Which of the following stain has been used?&nbsp;<i>&nbsp;</i></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/08/io58.jpg\" alt=\"\" width=\"300\" height=\"234\"></p>",
    "unique_key": "Q5803106",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088069,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. A) Prussian blue</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">This <strong>iron stain</strong>, also known as <strong>Perls' Prussian blue</strong>, detects <strong>ferric iron by turning it blue</strong>. It is specifically <strong>used for the detection of iron overload in tissues</strong>, as seen in <strong>hemochromatosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Alcian blue:&nbsp;Alcian blue stains acidic polysaccharides </strong>and <strong>glycosaminoglycans in tissues blue</strong>, which is used to <strong>identify mucopolysaccharides</strong>. It is not used for iron staining.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C: Von Kossa:&nbsp;</strong>The <strong>Von Kossa stain </strong>is used to <strong>detect calcium salts</strong>, which <strong>appear black under microscopy. </strong>This would not be the appropriate stain for identifying iron deposits in the liver.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D: Crystal violet:&nbsp;Crystal violet </strong>is a <strong>basic dye </strong>that <strong>stains the components of cells purple </strong>or <strong>blue-violet </strong>and is often <strong>used in Gram staining of bacteria</strong>. It is not used for the detection of iron in tissue samples.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">This <strong>stain is used to detect iron deposits </strong>in <strong>tissues </strong>and is characteristic of the <strong>pathology seen in hemochromatosis</strong>, where <strong>iron accumulation occurs </strong>within the hepatocytes.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 849</strong></span></p>",
    "correct_choice_id": 59908,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14988,
    "choices": [
      {
        "id": 59912,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Females do not increased incidence than males</span></p>"
      },
      {
        "id": 59913,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Has good prognosis</span></p>"
      },
      {
        "id": 59914,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Not associated with liver cirrhosis</span></p>"
      },
      {
        "id": 59915,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum AFP levels are usually &gt; 1000 mg/litre</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">True about Fibrolamellar carcinoma of Liver is all, <i>except</i>:</span></p>",
    "unique_key": "Q3339221",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088070,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) Serum AFP levels are usually &gt; 1000 mg/liter</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Fibrolamellar carcinoma </strong>(FLC) of the <strong>liver is a rare variant of hepatocellular carcinoma </strong>(HCC) that has <strong>distinct clinical </strong>and <strong>pathological features</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Unlike <strong>typical hepatocellular carcinoma</strong>, <strong>fibrolamellar carcinoma </strong>is associated with <strong>normal or only mildly elevated alpha-fetoprotein </strong>(AFP) <strong>levels</strong>. <strong>AFP levels </strong>are generally <strong>not as markedly elevated </strong>as in other types of hepatocellular carcinoma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:&nbsp;</strong>Unlike <strong>conventional hepatocellular carcinoma</strong>, <strong>fibrolamellar carcinoma </strong>does not show a significant <strong>gender predilection</strong>. Both males and females are affected, and there is no clear male predominance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong>Generally, <strong>fibrolamellar carcinoma </strong>is associated with a <strong>better prognosis </strong>compared to <strong>conventional hepatocellular carcinoma</strong>. It often <strong>occurs in younger individuals </strong>and is <strong>less likely to be associated with cirrhosis</strong>. Surgical resection is the primary treatment, and if the tumor is resected early, the prognosis can be relatively favorable.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:&nbsp;Fibrolamellar carcinoma </strong>is characteristically <strong>not associated with liver cirrhosis</strong>. This is in contrast to conventional hepatocellular carcinoma, which is often linked to cirrhosis, especially in the setting of chronic liver diseases.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>AFP levels </strong>in <strong>fibrolamellar variant </strong>are generally <strong>not as markedly elevated </strong>as in other types of hepatocellular carcinoma</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10th/ 873</strong></span></p>",
    "correct_choice_id": 59915,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14994,
    "choices": [
      {
        "id": 59936,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
      },
      {
        "id": 59937,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hepatoblastoma</span></p>"
      },
      {
        "id": 59938,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma</span></p>"
      },
      {
        "id": 59939,
        "text": "<p><span style=\"font-size:12.0pt;\">Hemangioma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year-old man with a history of chronic hepatitis B and cirrhosis presents with abdominal pain, unintentional weight loss, and fatigue. Imaging studies reveal a liver mass, and a biopsy confirms the diagnosis of the most common primary malignant tumor of the liver in adults. What is the likely diagnosis?&nbsp;</span></p>",
    "unique_key": "Q4568569",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088071,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C) Hepatocellular carcinoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The <strong>most common primary malignant tumor </strong>of the <strong>liver in adults is hepatocellular carcinoma</strong>. <strong>HCC arises </strong>from <strong>hepatocytes </strong>and is closely <strong>associated with chronic liver diseases</strong>, particularly cirrhosis caused by viral hepatitis (hepatitis B and C), alcoholism, and non-alcoholic fatty liver disease.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>HCC </strong>is the <strong>most common type of primary liver cancer </strong>in <strong>adults </strong>and often <strong>arises in the setting of chronic liver disease</strong>, such as <strong>cirrhosis from hepatitis B or C</strong>, <strong>alcohol abuse</strong>, or <strong>nonalcoholic fatty liver disease</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation</u>:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A: Squamous cell carcinoma:&nbsp;</strong>Squamous cell carcinoma is a <strong>type of cancer </strong>that usually <strong>arises in the skin </strong>or <strong>tissues </strong>that line the internal organs, but it is not typically found in the liver.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Hepatoblastoma:</strong> Hepatoblastoma is a <strong>rare malignant liver tumor </strong>that is most common in children, not adults.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hemangioma:</strong> Cavernous hemangioma is the most common benign liver tumor.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">It is the <strong>most common primary malignant tumor </strong>of the <strong>liver in adults </strong>and is often <strong>associated with chronic liver disease </strong>such as <strong>hepatitis B-induced cirrhosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10th/ 870</strong></span></p>",
    "correct_choice_id": 59938,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15019,
    "choices": [
      {
        "id": 60036,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary biliary cirrhosis </span></span></span></span></p>"
      },
      {
        "id": 60037,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary sclerosing cholangitis </span></span></span></span></p>"
      },
      {
        "id": 60038,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extrahepatic biliary fibrosis </span></span></span></span></p>"
      },
      {
        "id": 60039,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital hepatic fibrosis</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old patient presents with recurrent episodes of jaundice and pruritus. Liver biopsy reveals characteristic &quot;onion skin fibrosis&quot; around the bile ducts. Laboratory tests show elevated alkaline phosphatase levels. Which of the following conditions is most likely associated with the histological finding described?</span></span></p>",
    "unique_key": "Q1972053",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088072,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Primary sclerosing cholangitis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&quot;Onion skin fibrosis&quot; </strong>refers to a characteristic <strong>histological finding in primary sclerosing cholangitis</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary sclerosing cholangitis </strong>is a <strong>chronic, progressive cholestatic liver disease </strong>characterized by&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>inflammation </strong>and <strong>fibrosis of the intrahepatic </strong>and <strong>extrahepatic bile ducts</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary biliary cirrhosis </strong>is a <strong>distinct autoimmune liver disease </strong>characterized by the <strong>destruction of small bile ducts </strong>within the <strong>liver</strong>. <strong>&quot;Onion skin fibrosis</strong>&quot; is <strong>not a typical histological finding </strong>in <strong>primary biliary cirrhosis</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Extrahepatic biliary fibrosis</strong>: This term is nonspecific and not commonly used as a diagnosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital hepatic fibrosis </strong>is a <strong>developmental disorder of the liver </strong>and is not associated with onion skin fibrosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary sclerosing cholangitis&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>associated with characteristic &quot;onion skin fibrosis</strong>&quot; <strong>around bile ducts </strong>and <strong>elevated alkaline phosphatase levels</strong>, reflecting bile duct inflammation and fibrosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 861</span></span></strong></span></span></p>",
    "correct_choice_id": 60037,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15021,
    "choices": [
      {
        "id": 60044,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Nodular type of cholangiocarcinoma</span></p>"
      },
      {
        "id": 60045,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fibrolamellar hepatocellular carcinoma</span></p>"
      },
      {
        "id": 60046,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Gall bladder carcinoma</span></p>"
      },
      {
        "id": 60047,
        "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 58-year-old patient presents with painless jaundice, pruritus, and weight loss. Imaging studies reveal a nodular mass obstructing the bile ducts at the hepatic hilum. Biopsy confirms the diagnosis of a Klatskin tumor. Which of the following best describes this tumor?</span></p>",
    "unique_key": "Q9683734",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088073,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Nodular type of cholangiocarcinoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Cholangiocarcinomas </strong>are <strong>classified into intrahepatic </strong>and <strong>extrahepatic forms</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Eighty to 90% of the tumors are <strong>extrahepatic. </strong>The extrahepatic forms include perihilar tumors known as <strong>Klatskin tumors</strong>, which are located at the <strong>junction of the right and left hepatic ducts </strong>forming the com\u00admon hepatic duct, and distal bile duct tumors.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Most extrahepatic CCAs appear as <strong>firm, gray nodules </strong>within the bile duct wall</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Klatskin tumors generally have slower growth than other CCAs, show <strong>prominent fibrosis</strong>, and infrequently involve distal metastases.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A <strong>Klatskin tumor </strong>is a <strong>type of cholangiocarcinoma </strong>that <strong>occurs at the hepatic hilum </strong>where the <strong>right and left hepatic ducts join</strong>. It is often nodular and can obstruct the bile ducts.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B: Fibrolamellar hepatocellular carcinoma:&nbsp;</strong>This is a <strong>distinct variant of hepatocellular carcinoma </strong>that typically affects younger individuals and has a characteristic appearance on imaging and histology, different from Klatskin tumors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C: Gall bladder carcinoma:</strong>&nbsp; Gall bladder carcinoma typically <strong>arises in the gall bladder itself </strong>and not in the bile ducts, hence it is not a Klatskin tumor.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D: Hepatocellular carcinoma:&nbsp;</strong>This is a <strong>primary liver cancer </strong>that <strong>originates from hepatocytes</strong>. A Klatskin tumor, however, arises from the biliary epithelium at the confluence of the left and right hepatic bile ducts.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:&nbsp;</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Klatskin tumors </strong>are <strong>nodular cholangiocarcinomas </strong>located at the <strong>hepatic hilum </strong>and are known for <strong>causing biliary obstruction</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10th/871</strong></span></p>",
    "correct_choice_id": 60044,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15022,
    "choices": [
      {
        "id": 60048,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilson&rsquo;s disease </span></span></span></span></p>"
      },
      {
        "id": 60049,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha 1 antitrypsin deficiency </span></span></span></span></p>"
      },
      {
        "id": 60050,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemochromatosis </span></span></span></span></p>"
      },
      {
        "id": 60051,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary biliary cirrhosis</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old patient presents with fatigue, hepatomegaly, and neurological symptoms such as tremors and dysarthria. Ophthalmic examination reveals a brownish ring around the cornea. Laboratory tests show elevated urinary copper levels and decreased ceruloplasmin levels. Which of the following conditions is most likely responsible for the observed ophthalmic finding in this patient?</span></span></p>",
    "unique_key": "Q5957769",
    "question_audio": null,
    "question_video": null,
    "map_id": 19088074,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Wilson&rsquo;s disease</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&quot;Kayser-Fleischer ring&quot; </strong>is a <strong>brownish ring of copper deposits </strong>that can be <strong>observed in the cornea of the eye</strong>. This <strong>ring is a characteristic finding in Wilson&#39;s disease</strong>, an <strong>inherited disorder </strong>of <strong>copper metabolism</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wilson&#39;s disease </strong>is an <strong>autosomal recessive disorder </strong>of <strong>copper metabolism </strong>that leads to <strong>copper accumulation in various tissues</strong>, including the <strong>liver and brain</strong>. The <strong>Kayser-Fleischer ring</strong>, a <strong>brownish or greenish ring </strong>around the <strong>cornea due to copper deposition</strong>, is a hallmark of this condition.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Alpha-1 antitrypsin deficiency:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-1 antitrypsin deficiency is a <strong>genetic condition </strong>that can <strong>lead to liver and lung disease </strong>due to the <strong>accumulation of abnormal alpha-1 antitrypsin protein </strong>in the <strong>hepatocytes</strong>. It does not cause the Kayser-Fleischer ring.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hemochromatosis:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemochromatosis is a <strong>hereditary condition </strong>characterized by <strong>excessive iron accumulation </strong>in various <strong>organs </strong>but does not lead to the formation of a Kayser-Fleischer ring.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Primary biliary cirrhosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary biliary cirrhosis is an <strong>autoimmune liver disease </strong>characterized by the <strong>destruction of intrahepatic bile ducts</strong>. While it may lead to cirrhosis and associated symptoms, it does not cause the ophthalmic findings seen in Wilson&rsquo;s disease.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of a Kayser-Fleischer ring</strong>, <strong>neurological symptoms</strong>, <strong>elevated urinary copper levels</strong>, and <strong>decreased ceruloplasmin </strong>are all diagnostic of <strong>Wilson&#39;s disease</strong>, a disorder of copper metabolism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> /850 </span></span></strong></span></span></p>",
    "correct_choice_id": 60048,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00086 Mid Day Module (Pathology-6)';
        const quizFilename = '00086-mid-day-module-pathology-6-ee632297.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>